NDC 71335-1314 – Ondansetron

Ondansetron 4 mg/1 · Tablet, Orally Disintegrating · Oral

Human Prescription Drug

Product NDC71335-1314

Product details

Brand name
Ondansetron
Generic name
Ondansetron
Labeler
Bryant Ranch Prepack
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
ANDA · ANDA090469
Marketed since
April 12, 2010
Listing expires
December 31, 2026
Pharmacologic class
Serotonin-3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Ondansetron →

Package NDC codes (10)

Package NDCDescriptionSince
71335-1314-090 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-0)Sep 9, 2019
71335-1314-130 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-1)Sep 20, 2019
71335-1314-220 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-2)May 14, 2020
71335-1314-310 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-3)Sep 11, 2019
71335-1314-46 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-4)Sep 16, 2019
71335-1314-560 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-5)Nov 26, 2019
71335-1314-69 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-6)Apr 3, 2024
71335-1314-75 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-7)Oct 18, 2019
71335-1314-815 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-8)Oct 14, 2019
71335-1314-93 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-9)Nov 5, 2020

Other Ondansetron products